BridgeMD
Tests treatment safety and results for Blood Sugar
Official title Clinical Study to Evaluate the Effects and Safety of Green Tea Extract on Blood Glucose Regulation
ClinicalTrials.gov ID: NCT06592365
What this study is testing
- What it's testing
- This study was conducted to investigate the effects of green tea extracts on reducing blood glucose level
- Time commitment: about 12 weeks
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 64. Healthy volunteers may be eligible.
You may be able to join if
- Males and females aged between 19 to 64 years
- BMI between 18.5 and 29.9kg/m²
- fasting blood glucose between 100 and 139 mg/dL (Note: if some people with blood glucose range of 126 - 139 mg/dL, those who are taking or requre...
- people who voluntarily decide to participate in this study and sign the informed consent form.
You likely can't join if
- Individuals taking to obesity, dyslipidemia, or uncontrolled hypertension at the screening
- Individuals diagnosed with diabetes and who have taken medications related to blood glucose
- Individuals congenital enzyme deficiencies related to sugar metabolism.
- with hypersensitivity to the test food or ingredients(e.g., green tea, caffeine).
- Individuals ongoing treatment diseases significantly related glucose metabolism.
- Individuals with a history of surgery significantly related to glucose metabolism within the last 6 months
See the full eligibility criteria
- Males and females aged between 19 to 64 years
- BMI between 18.5 and 29.9kg/m²
- fasting blood glucose between 100 and 139 mg/dL (Note: if some people with blood glucose range of 126 - 139 mg/dL, those who are taking or requre medication must be excluded to meet ethical standards.)
- people who voluntarily decide to participate in this study and sign the informed consent form.
- Individuals taking to obesity, dyslipidemia, or uncontrolled hypertension at the screening
- Individuals diagnosed with diabetes and who have taken medications related to blood glucose
- Individuals congenital enzyme deficiencies related to sugar metabolism.
- with hypersensitivity to the test food or ingredients(e.g., green tea, caffeine).
- Individuals ongoing treatment diseases significantly related glucose metabolism.
- Individuals with a history of surgery significantly related to glucose metabolism within the last 6 months
- diagnosed with gastrointestinal diseases, cardiovascular diseases, uncontrolled chronic medical conditions, thyroid disorders, or active malignant tumors requiring medication
- Individuals with liver function impairment or acute or chronic hepatitis or liver cirrhosis
- Individuals with renal disorder
- Individuals with a weight change of 5 kg or more within the last 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 64 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.